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Abstract: Aedes aegypti is a principal vector responsible for the transmission of dengue 
viruses (DENV). To date, vector control remains the key option for dengue disease 
management. To develop new vector control strategies, a more comprehensive 
understanding of the biological interactions between DENV and Ae. aegypti is required. In 
this study, a cDNA library derived from the midgut of female adult Ae. aegypti was used in 
yeast two-hybrid (Y2H) screenings against DENV2 envelope (E) protein. Among the many 
interacting proteins identified, carboxypeptidase B1 (CPB1) was selected, and its 
biological interaction with E protein in Ae. aegypti primary midgut cells was further 
validated. Our double immunofluorescent assay showed that CPB1-E interaction occurred 
in the endoplasmic reticulum (ER) of the Ae. aegypti primary midgut cells. Overexpression 
of CPB1 in mosquito cells resulted in intracellular DENV2 genomic RNA or virus particle 
accumulation, with a lower amount of virus release. Therefore, we postulated that in 
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Ae. aegypti midgut cells, CPB1 binds to the E protein deposited on the ER intraluminal 
membranes and inhibits DENV2 RNA encapsulation, thus inhibiting budding from the ER, 
and may interfere with immature virus transportation to the trans-Golgi network. 
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1. Introduction 
The Aedes aegypti mosquito is more widely dispersed today, exposing a third of the world’s 
population to the risk of infections with one or more of the four dengue virus serotypes (DENV1-4). 
DENV is a positive-sense, single-stranded RNA virus with a total genome size of approximately 11 kb. 
It belongs to the Flavivirus genus of the Flaviviridae family. In its host, the DENV genome is 
translated into three structural proteins, C, prM and E, and seven non-structural proteins, NS1, NS2a, 
NS2b, NS3, NS4a, NS4b and NS5, from a single open reading frame. The multiple proteins are then 
cleaved into individual components via proteolytic cleavage by either viral or host proteases. DENV 
assembly occurs in the rough endoplasmic reticulum (rER) [1]. Then, the virus is channeled into the 
trans-Golgi network (TGN) for maturation to occur [2,3], followed by virus release from the infected 
host cell. 
Recently, there has been an increased interest in understanding viral tropism and the molecular 
activities of DENV in Ae. aegypti and Ae. albopictus [4–7]. Following a blood meal from an infected 
human, DENVs multiply in the midgut of the mosquito for seven to 14 days. The viruses are 
disseminated from the midgut and proliferate in the salivary gland, where the virus is transmitted to 
another host when the infective mosquito takes another blood meal. The vital role of mosquitoes in the 
transmission cycle of DENV makes vector control an important strategy in disease management. The 
use of pesticides, however, has resulted in various issues, which hinder the on-going dengue 
management efforts [8–14]. Other strategies for mosquito control must therefore be considered. Some 
of these include directing research towards determining mechanisms of viral survival, virulence and 
tropism in the Ae. aegypti mosquito. 
In nature, the mosquito vectorial capacity has been linked to the mosquito midgut epithelial barrier, 
midgut escape barrier and salivary escape barrier [15]. These differentiated tissues are only present in 
adult mosquitoes. In this study, female adult Ae. aegypti midgut tissues were collected for cDNA 
library construction and then used for yeast two-hybrid (Y2H) screening to identify interacting dengue 
virus proteins. 
We constructed the cDNA library using a homologous recombination-mediated approach with the 
Gal4 activation domain-based vector, pGADT7. This library was screened against the DENV2 E 
protein, resulting in the identification of a number of interacting proteins, with carboxypeptidase B1 
(CPB1) as one of the predominant DENV2 E protein interaction partners. To date, there have been no 
studies reporting the possible role of Ae. aegypti CPB1 protein during DENV infection. This study 
reports the molecular interactions between Ae. aegypti CPB1 and the DENV2 E protein, as well as the 
role of CPB1 in regulating viral replication and release from Ae. aegypti primary midgut cells. 
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2. Materials and Methods 
2.1. Virus and Cell Cultures 
Dengue virus type 2 (MY89-88549, AJ556804) was kindly provided by Prof. Sazaly Abu Bakar, 
University of Malaya. The virus was propagated in C6/36 (ATCC® CRL-1660™) and Vero cells 
(ATCC® CCL-81™) until cytopathic effects were observed. The titer of DENV2 grown in C6/36 and 
Vero cells was determined in Vero cells and was 104 and 106 median tissue culture infective dose/mL 
(TCID50/mL), respectively. Vero cells were incubated at 37 C with 5% CO2, in minimal essential 
medium (MEM) supplemented with 10% fetal bovine serum (FBS), 1% PSK (working concentration 
of 0.5 U/mL of penicillin “G” sodium, 0.5 mg/mL of streptomycin and 1 mg/mL kanamycin sulfate) and 
1% HEPES buffer (Gibco®, Life Technologies, Carlsbad, CA, USA). The C6/36 cells were incubated at 
28 C with 5% CO2, maintained in minimal essential medium (MEM) identical to the supplements 
described above, with 1.5% HEPES buffer. Both cell lines were passaged once every 4–5 days. 
2.2. Plasmid Construction and Yeast Transfection 
The DENV2 envelope (E) gene (forward primer: AATGCGTTGTATAGGAATATC; reverse 
primer: AACCACTATCGGCCTGCACCAT) was cloned in-frame into the pGBKT7 plasmid 
(Clontech, Mountain View, CA, USA) and named pGBKT7-E. The plasmid was transfected into the 
yeast strain Y2HGold using the lithium/acetate method described previously [16]. Positively-
transfected yeast colonies were maintained on selective agars with depleted tryptophan (SD/-Trp, 
synthetic dropout media without tryptophan) and cryopreserved at −80 C until use. 
2.3. Aedes aegypti Mosquitoes 
Ae. aegypti mosquitoes (Linnaeus) [17,18] were maintained in the insectarium at the Universiti 
Sains Malaysia (USM), School of Biological Sciences, at 28 ± 1 °C under 70%–75% relative humidity, 
with a light/dark cycle of 14 h/10 h. The larvae were reared in round trays with mineral water 
(approximately 3 cm height) and provided with cat food (chicken sourced). The adults were fed with 
sterilized 10% sucrose solution ad libitum. 
2.4. Aedes aegypti Primary Midgut Cell Preparations 
Mosquitoes were cold anaesthetized, and all dissections were performed under sterile conditions 
following previously described protocols [19,20] with minor modifications. In brief, the mosquitoes 
were surface sterilized with a 70% ethanol solution [21] and rinsed with sterile phosphate-buffered 
saline (PBS). Ae. aegypti midguts were carefully dissected [22] under a dissecting microscope  
(15× magnification). The midguts were immersed in sterile PBS solution supplemented with  
1× penicillin-streptomycin-neomycin (PSN) antibiotic mixture (Gibco®, Life Technologies) and 
trypsinized with 1× Krebs-Ringer bicarbonate solution supplemented with 0.25% trypsin (37 °C  
for 25 minutes). The cells were pelleted (500× g, 4 °C, 15 min), resuspended in MEM media 
supplemented with 10% FBS and incubated in 96-well plates (28 °C, 5% CO2) with one passage  
every 12 days. 
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2.5. cDNA Library Construction 
A total of 50 dissected Ae. aegypti primary midguts [22] were subjected to total RNA extraction 
using TRIzol® Reagent (Invitrogen™, Life Technologies). Following the manufacturer’s instructions 
and previously reported studies [23,24], first- and second-strand cDNA were synthesized using the 
Make Your Own “Mate & Plate™” Library System (Clontech). Double-stranded cDNA was purified, 
and nucleic acids less than 400 bp were discarded using Chroma Spin™ TE-400 Columns (Clontech). 
About 4.16 µg (10 µL) of purified double-stranded cDNA, in conjunction with 3 µg linearized 
pGADT7-rec vector and 200 µg denatured Yeastmaker Carrier DNA (Clontech) were mixed and 
transformed concurrently into competent yeast Y187 cells [16]. Then, the pelleted cells were 
re-suspended in 15 mL sterile 0.9% (w/v) NaCl solution prior to spreading on selection agar plates with 
depleted leucine (SD/-Leu). To detect transformation efficiency, 100 µL was spread in dilutions of 10−1, 
10−2 and 10−3 on 100-mm SD/-Leu agar plates, and others were spread on 150-mm plates for 150 µL 
each (a total of 100 plates). After incubation at 30 °C for 96 hours, the surviving colonies were counted 
to calculate the library titer and the number of independent clones [25]. Then, the plates were 
harvested with 5 mL YPDA (yeast extract solution with peptone, dextrose, and adenine) freezing 
medium each. All liquids were collected in a sterile 1-L flask and mixed well. After that, they were 
stored in 1-mL or 50-mL aliquots at −80 °C until use. 
2.6. Yeast Two-Hybrid Screening 
Y2H screening was conducted according to previous studies [26,27] and the manufacturer’s 
instructions. Prior to mating, Y2HGold was plated on SD/-Ade/-His/-Trp agar supplemented with  
X-α-gal (40 µg/mL) for the auto-activation test. In the absence of the pGADT7 plasmid, no  
auto-activation of any reporter was detected in our Y2HGold harboring pGBKT7-E. Yeast mating was 
conducted aseptically by inoculating an overnight 5-mL Y2Hgold culture (bait) with a 1-mL library 
aliquot (prey). The mixture was diluted to 50 mL using 2× YPDA broth. Mating was allowed for  
24 hours at 30 °C with 45-rpm orbital shaking. Then, the yeast cells were pelleted and spread on  
low-stringency selection agar SD/-Leu/-Trp (DDO) in the presence of Aureobasidin A (Aba, 125 ng/mL) 
and X-α-gal, followed by high-stringency selection agar SD/-Leu/-Trp/-Ade/-His (QDO) supplemented 
with Aba and X-α-gal. After a 96-hour incubation at 30 °C, the plasmids were extracted from the 
surviving blue yeast colonies and sequenced for cDNA insert identification (BLAST). 
2.7. Mammalian Two-Hybrid Analysis 
Mammalian two-hybrid analysis was performed as a complementary approach to the Y2H [28]. The 
cDNA of DENV2 E and Ae. aegypti CPB1 were cloned in-frame into the pM (GAL4 DNA-BD) and 
pVP16 (AD) cloning vectors (Matchmaker Mammalian Assay Kit 2, Clontech), respectively. Using the 
CalPhos™ Mammalian Transfection Kit (Clontech), Vero cells were co-transfected with different 
plasmid cocktails consisting of 5 µg each pM-E, pVP16-CPB1 and pG5SEAP according to the scheme 
in Figure 1. The transfected cells were incubated (37 °C, 5% CO2, 48 hours), and the culture media 
were harvested for SEAP (secreted alkaline phosphatase) activity analysis using the GreatEscAPe™ 
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SEAP Chemiluminescence Detection Kit (Clontech). Chemiluminescent signals were detected using a 
PerkinElmer VICTOR™ X5 Multilabel Plate Reader. This assay was conducted in biological triplicates. 
2.8. Double Immunofluorescence Assay 
This assay was performed using a previously-described procedure [29] with minor modifications. 
Anti-E (GeneTex, GTX43296) and anti-CPB1 antibody (Abnova, H00001360-D01) were obtained 
commercially. Ae. aegypti primary midgut cells were infected with DENV2 at multiplicity of infection 
(MOI) of 10, and viral proliferation was allowed for 48 hours. Live cells were stained with 
ER-Tracker™ Blue-White Dapoxyl™ (1 µM/mL) (Molecular Probes®, Life Technologies™), fixed 
(4% paraformaldehyde, 1× Hank's Balanced Salt Solution (HBSS), 10 min), permeabilized (0.25% 
Triton X-100, 1× HBSS, 10 min), blocked (1% BSA, 1× HBSS, 1 hour) and incubated with primary 
(anti-E and anti-CPB1 antibodies, 1:2000 dilution, 1 hour) and secondary antibodies (AlexaFluor® 488, 
AlexaFluor® 594, 1:2000 dilution, 1 hour). The slides were mounted and viewed under an IX81 confocal 
microscope (Olympus). This assay was conducted at room temperature, unless otherwise stated. 
2.9. Co-Immunoprecipitation Analysis 
Ae. aegypti CPB1 and DENV2 E protein were co-immunoprecipitated using the Dynabeads® 
Co-Immunoprecipitation Kit (Invitrogen™, Life Technologies) following the manufacturer’s 
instructions. In brief, DENV2-infected (MOI: 1) Ae. aegypti primary midgut cells were pelleted and 
lysed with lysis buffer (110 mM KOAc, 0.5% Triton X-100, 100 mM NaCl, 2 mM MgCl2, 1 mM DTT 
and 0.8 mM PMSF, pH 7.4). Anti-CPB1 and anti-E antibody-coupled resins were prepared according 
to the manufacturer’s instructions. In two independent experiments, antibody-coupled resins were 
mixed with cell lysates on a tube rotator (4 °C, 30 min). The resin-antibody-proteins complexes were 
collected using magnetic stands. The complexes were washed three times (0.05% Tween-20, 100 mM 
NaCl, 2 mM MgCl2 and 0.8 mM PMSF, pH 7.5) before the final elution of the protein complexes. The 
eluents were subjected to western blot assay with both primary antibodies, anti-E antibody (Abnova, 
MAB8902) and anti-CPB1 antibody (Abnova, H00001360-D01). Alkaline phosphatase (AP)-conjugated 
anti-rabbit antibody (host: goat) was used as the secondary antibody. The bands were visualized after 
incubation with the 5-bromo-4-chloro-3-indolyl-phosphate/nitro blue tetrazolium (BCIP/NBT) 
substrate. In parallel, 10% cellular lysate and non-antibody-coated beads were included in the western 
blot assays. 
2.10. Molecular Docking Analysis 
The three-dimensional structure of the DENV E was obtained from the Protein Data Bank (PDB: 
1OAN). For Ae. aegypti CPB1, the protein structure was predicted using Iterative Threading 
ASSEmbly Refinement (I-TASSER) [30,31]. The PatchDock algorithm [32] was used to determine a 
rigid docking model between the CPB1 and E protein. The three-dimensional transformations of the 
Cartesian coordinate of the proteins were further refined using the FireDock algorithm [33,34]. The 
complex structure with the lowest interaction energy was used for further analyses. 
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2.11. CPB1 Upregulation Study 
CPB1 upregulation studies were conducted in insect [35] and mammalian cell lines [36], C6/36 and 
Vero cells, respectively. Ae. aegypti CPB1 cDNA was cloned in-frame into the pIB/V5-His and 
pcDNA3.1(+) plasmids (Invitrogen™, Life Technologies). The cells were seeded on 24-well plates at 
3 × 105 cells/well one day before transfection. A total of 2 µg of plasmid constructs were transfected 
into each respective well using Lipofectamine® 2000 transfection reagent (Invitrogen™, Life 
Technologies). CPB1 expression was allowed (28 °C, 5% CO2, 48 hours) before DENV2 infection 
(MOI: 1). After 48 hours, the cells and media were harvested for RNA extraction using the RNeasy Kit 
(Qiagen, Valencia, CA, USA). The RNA concentration and quality were determined using a 
NanoPhotometer® (Implen, München, Germany). The cDNA was constructed with the RevertAid 
Premium First-strand cDNA Synthesis Kit (Fermentas, Leicester, U.K.). Quantitative real-time PCR 
(qPCR) was conducted using a StepOnePlus qPCR System (Applied Biosystem®, Life Technologies) 
with the Power SYBR® Green PCR Master Mix (Applied Biosystems®, Life Technologies). The 
temperature cycle was as follows: 95 °C, 10 min; 40 cycles of 95 °C, 15 s, 60 °C, 30 s, and 72 °C, 40 s. 
A melt curve setting was included. The relative quantification of DENV2 genomic RNA was assessed 
using the comparative CT (∆∆CT) algorithm [37]. This assay was conducted in triplicate. Results 
expressed as ΔΔCT were reported as the mean standard deviation and analyzed using paired Student’s 
t-test. p values <0.05 were considered statistically significant. 
3. Results  
3.1. Ae. aegypti Midgut cDNA Library Construction 
The library titer and the total number of independent clones were calculated according to previous 
reported formulas [23,25]. Based on the colony number on SD/-Leu plates, the Y187 library titer 
(cfu/mL) was determined at 7.5 × 104, which met the minimum requirement standard (6.7 × 104 cfu/mL) 
of the manufacturer (Clontech). The total number of independent clone, which was an indication of the 
cDNA library complexity, was 3.75 × 107.  
3.2. CPB1 Protein Interacts with the DENV2 E Protein 
 Using the Y2H assays, a total of 265 surviving blue yeast colonies were obtained from 
low-stringency selection agars (SD/-Leu/-Trp). This number was reduced to 56 by eliminating 
false-positive interactors on high-stringency selection agars (SD/-Leu/-Trp/-His/-Ade). The final step 
of the assay, including the sequencing of these colonies, resulted in 11 positive candidate proteins, 
because of multiple copies of sequences of frequently-interacting protein candidates. CPB1 was 
identified in seven of 56 yeast colonies surviving on high-stringency selecting agars.  
A mammalian two-hybrid (M2H) assay was also performed as a complementary experiment to the 
Y2H to confirm the interactions. Vero cells were co-transfected with the pM and pVP16 plasmids 
along with a pG5SEAP reporter vector, according to the scheme in Figure 1 (the full experimental 
procedure is described in the Materials and Methods section). pG5SEAP is transcriptionally activated 
by physical interaction between pM- and pVP16-conjugated proteins and expresses SEAP (secreted 
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alkaline phosphatase), which can be determined maximally 48 hours following transfection. The SEAP 
reporter gene encodes alkaline phosphatase without the membrane-anchoring domain, which contains 
the protein to be secreted from the transfected cells into the culture medium. Therefore, the level of 
SEAP activity is a direct quantification of protein-protein interactions, because its activity is directly 
proportional to the intracellular amount of mRNA and proteins [38,39]. The results showed that the 
CPB1-E interaction was relatively strong (Figure 1A) compared to the positive (Figure 1F) and negative 
controls (Figure 1B–E). The positive controls were Vero cells transfected with the pM3-VP16 plasmid, 
which encodes a Gal4 DNA binding domain fused to the transcription activator, VP16. On the other 
hand, negative controls consisted of mock-transfected controls (Figure 1B), empty pM and pVP16 
controls (Figure 1C), pM with insert control (Figure 1D) and pVP16 with insert control (Figure 1E). 
These negative-control samples showed a minimal chemiluminescence level, which denoted the 
genuine interaction of CPB1-E. 
 
Figure 1. Mammalian two-hybrid assays confirm the physical interaction of CPB1 and E 
protein in Vero cells. The columns show the mean values and the error bars are the SD of 
three samples (n = 3). Each column represents a treatment and is labelled “+” for the 
plasmid transfected and “-” for the plasmid that is absent. (A) Interaction between CPB1 
and E proteins. The secreted alkaline phosphatase (SEAP) activity is significantly higher 
than the negative controls. (B–E) Various negative controls in the presence/absence of 
different combinations of plasmid construct. (F) Positive controls transfected with  
pM3-VP16, which expresses a fusion of the GAL4 DNA-binding domain to the VP16 
activation domain. Therefore, the positive controls had the highest SEAP activity.  
The media was harvested 48 hours post-transfection. 
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3.3. CPB1 Co-Localizes with Dengue Virus 2 E Protein in the Endoplasmic Reticulum (ER) of  
Ae. aegypti Primary Midgut Cells 
The distribution of CPB1 in mosquito cells has not been previously assessed. Therefore, we 
investigated the cellular localization of CPB1 in Ae. aegypti midgut cells during DENV2 infection. 
Figure 2 shows the DENV2-infected (Figure 2A) and mock-infected primary midgut cells (Figure 2B). 
CPB1 was found throughout the cells, including the nuclei, regardless of the presence of DENV2  
(Figure 2A,B, CPB1). Not all midgut cell types were susceptible to DENV2 infection, and the 
distribution of DENV2 varies between cell types (Figure 2A, DENV2). The CPB1 and E proteins  
co-localize in proximity to the nucleus, in the ER of DENV2-infected Ae. aegypti midgut cells (Figure 
2A, white arrows in the close-up view). The ER in the cytoplasm was stained blue surrounding a 
“hollow” region in the majority of cells (Figure 2A,B, endoplasmic reticulum). These hollow regions 
are the nuclei, labelled “N”. No DENV2 was detected in the mock-infected control (Figure 2B, DENV2). 
 
Figure 2. Cellular localization of CPB1 and DENV2 in the ER of Aedes aegypti primary 
midgut cells. (A) DENV2-infected mosquito primary midgut cells. (B) Mock-infected 
control. The midgut cells were isolated from female adult Ae. aegypti and maintained in 
MEM media supplemented with 10% FBS. At 48 hpi, the cells were stained with 
ER-Tracker™ (blue, endoplasmic reticulum), fixed and stained for DENV2 (green, 
DENV2) and CPB1 (red, CPB1). The cells were mounted and viewed under a confocal 
microscope at 100× magnification with immersion oil (Olympus IX81). The ER, DENV2 
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and CPB1 images are overlaid into a merged image (merged). CPB1 is mainly observed 
throughout the cell cytoplasm (red), whereas DENV2 was found in DENV-infected cells 
(green). N, nuclei that were not stained to avoid confusion with the ER. White arrows in 
the close-up view indicate the co-localization of CPB1 and DENV2 within the blue ER 
regions. Bars = 20 µm. 
3.4. CPB1-E Protein Complexes Co-Immunoprecipitate from DENV2-Infected Ae. aegypti Primary 
Midgut Cells 
To further confirm the presence of CPB1-E protein complexes in Ae. aegypti during DENV2 
infection, a co-immunoprecipitation assay was performed using the cell lysates of DENV2-infected 
Ae. aegypti primary midgut cells. In this assay, 10% input of total cellular lysate indicates the amount 
of CPB1 and E proteins in the lysate (Figure 3A). The non-coated beads served as the “resin-only” 
control, which showed its ultra-low background binding ability (Figure 3B). Anti-CPB1 antibody-coupled 
resin pulled down the 46-kDa CPB1 and the 56-kDa E protein of DENV2 (Figure 3C, infected). The 
same two bands were observed when anti-E antibody-coupled resin was used in an independent 
co-immunoprecipitation experiment (Figure 3D, infected). In the uninfected controls, only CPB1 was 
pulled down when the anti-CPB1 antibody-coupled resin was used (Figure 3C, control). By contrast, 
no visible bands were observed when the anti-E antibody-coupled resin was used to 
co-immunoprecipitate E or CPB1 proteins from the uninfected cells (Figure 3D, control). The multiple 
bands, which were consistently observed with CPB1, were degraded products of this protein. The 
β-actin bands indicate that equal amounts of total cellular proteins were applied to each lane. 
 
 
Figure 3. Co-immunoprecipitation of CPB1 and E proteins from DENV2-infected and 
mock-infected Aedes aegypti primary midgut cell lysate. SDS-PAGE and western blot 
were performed using Dynabeads® conjugated with anti-CPB1 or anti-E antibodies.  
(A) 10% of the total cellular lysate. (B) Non-antibody-coated bead controls. Cell lysate 
Viruses 2014, 6 5037 
 
 
derived from DENV2-infected Ae. aegypti primary midgut cells (infected). Control, cell 
lysate derived from mock-infected Ae. aegypti primary midgut cells. (C,D) Anti-CPB1 and 
anti-E antibodies pulled down the CPB1 and E protein from DENV2-infected samples 
(infected). For controls, anti-CPB1 antibody pulled down the CPB1 protein ((C), control), 
whereas no band was observed in the same sample when anti-E antibody was used  
((D), control). Western blot analysis and β-actin protein levels of each sample are shown. 
3.5. In Silico Docking Suggests Possible CPB1-E Interaction 
The docking algorithm supports CPB1-E interaction with a binding energy of −22.7 kcal/mol. The 
result also suggests that CPB1 binds to domain II of the E protein (EII), where CPB1 binds to Thr66, 
Asn67, Thr68, Lys122 and Val251. Figure 4 shows the predicted CPB1-E protein complex, with CPB1 
illustrated in yellow, E in grey and red (grey: domain I and II; red: domain III) (Figure 4).  
 
 
Figure 4. In silico molecular docking surface structure of the Aedes aegypti CPB1 and 
DENV2 E protein (PDB: 1OAN). The CPB1 protein structure was predicted using Iterative 
Threading ASSEmbly Refinement (I-TASSER). The CPB1-E protein rigid docking model 
was predicted using the PatchDock algorithm and further refined using the FireDock 
algorithm. The CPB1-E docking algorithm suggests the lowest binding energy of −22.7 
kcal/mol. It also supports an interaction between CPB1 and the domain II of the E protein 
(EII), at residues Thr66, Asn67, Thr68, Lys122 and Val251. CPB1 is shown in yellow, and 
E in grey and red, where grey represents domains I and II and red represents domain III. 
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3.6. Overexpression of CPB1 in Mosquito C6/36 Cells Results in Intracellular Accumulation of 
DENV2 Genomic RNA and Viral Components 
The morphology of C6/36 cells was altered, with increased size and cell elongation after DENV2 
infection (Figure 5A). We also performed the relative quantification of intra- and extra-cellular 
DENV2 mRNA genomes of various C6/36 and Vero treatment groups by qPCR (Figure 5B,C). In both 
cell lines, DENV2 was not detected in either the cellular lysate or control sample media of 
non-infected controls (Figure 5B,C, mock and CPB1). For DENV2-infected samples, a higher amount 
of DENV2 genomic RNA was detected in the media (extracellular) compared to the cellular lysate 
(intracellular) (Figure 5B,C, DENV2). However, after Ae. aegypti CPB1 upregulation, opposite 
outcomes were observed between C6/36 and Vero cell lines. For C6/36 cells, the DENV2 genomic 
RNA was primarily detected intracellularly and was 9.4-fold higher than the control (p < 0.0001), 
whereas significantly less DENV2 was released (p < 0.0001) (Figure 5B, CPB1 + DENV2). For Vero 
cells, overexpressed CPB1 resulted in an increase in intracellular and extracellular viral accumulation 
compared to Vero cells without CPB1 overexpression (p < 0.05) (Figure 5C, CPB1 + DENV2). 
Distinct outcomes were observed for DENV2-infected C6/36 and Vero cells after CPB1 
overexpression (Figure 5B,C, CPB1 + DENV2). The results implicate that CPB1 may exclusively 
regulate DENV2 replication in mosquito cells, in order to confer infectivity to Ae. Aegypti while 
maintaining the healthiness of its vector mosquitoes. 
 
 
Figure 5. Intra- and extra-cellular DENV2 genomic RNA quantification of C6/36 and 
Vero cells during the upregulation of CPB1 expression. The cells were seeded in 24-well 
plates until 80% confluency, before pIB-CPB1 (for C6/36) or pcDNA-CPB1 (for Vero) 
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was transfected. Protein expression was allowed for 48 hours, followed by DENV2 
infection. Mock, mock-infected cells. CPB1, cells with upregulated CPB1 expression 
without DENV2 infection. DENV2, cells with DENV2 infection without CPB1 
upregulation. CPB1 + DENV2, cells with DENV2 infection after CPB1 upregulation. 
(A) The cell morphology of C6/36 cells with different treatments. (B,C) The columns show 
the mean values and the error bars are the standard deviation (SD) of three samples (n = 3). 
Cellular lysates and media were harvested for RNA extractions at 48 hpi. DENV2 genomic 
RNA was quantified using relative RT-qPCR. Excessive CPB1 leads to the intracellular 
accumulation of DENV2 genomic RNA in C6/36 cells (p < 0.0001), with a significant 
decrease in virus released into the extracellular media (p < 0.0001). By contrast, Vero cells 
exhibited an opposite trend, in which despite the accumulation of DENV2 genomic RNA 
(p < 0.05), the amount of virus released was directly proportional to the intracellular 
genomic RNA accumulation (p < 0.05). 
4. Discussion 
In this study, we identified and localized CPB1, an Ae. aegypti protein that interacts with the E 
protein of DENV2. CPB1 binds to the DENV2 E protein in yeast two-hybrid screenings and 
mammalian two-hybrid assay, and the interaction was confirmed by co-immunoprecipitation and 
co-localization assays. 
Various characteristics and functions of CPB1 have been reported in mosquito. The rapid induction 
of carboxypeptidase genes in the midgut of mosquito [40] and the upregulation of carboxypeptidase 
B1 and B3 in Ae. aegypti midgut have been demonstrated at 24 hours post blood meal (PBM) [41]. 
CPB1 is a well-known hydrolytic enzyme, which is involved in C-terminal peptide cleavage after 
blood ingestion [41]. Polyclonal antibodies against this mosquito-derived CPB1 antigen have also been 
shown to block the sexual development of malarial protozoan parasites in the midgut of Anopheles 
stephensi [42]. Carboxypeptidase D, a counterpart of CPB1, is a receptor for duck hepatitis B 
virus [43–45]. In addition, a recent study reported the interaction between carboxypeptidase A (CPA) 
and the DENV capsid (C) protein in the salivary gland of Ae. aegypti [6]. Based on these diverse roles 
of carboxypeptidases, we explored the functional relationship of Ae. Aegypti-derived CPB1 in response 
to DENV2 infections in the midgut cells of Ae. aegypti mosquito. 
To elucidate the mechanisms involved in the interaction between CPB1 and the E protein, it was 
necessary to determine where this interaction occurred. Macrophages are a primary target for dengue 
virus infection. Harris et al. showed that a vitellogenic-like carboxypeptidase (CPVL) was highly 
localized in the endoplasmic reticulum (ER) of human THP-1 monocytic cells and macrophages [46]. 
Specifically, in macrophages, CPVL is glycosylated and retained in the ER. The results of our study 
are consistent with this finding. We showed that using Ae. aegypti primary midgut cells, the CPB1 also 
localises in the ER and is not the surface of the cells (Figure 2). 
Studies have shown that CPB1 is naturally upregulated in mosquito midgut cells [41,47]. However, 
the natural upregulation of CPB1 during DENV infections in C6/36 and Vero cells has not been 
previously reported. To mimic the effect of upregulation of CPB1 in these cells, they were transfected 
with protein-expression plasmid containing the CPB1 cDNA insert, followed by DENV infection. 
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Interestingly, overexpression of CPB1 protein in DENV2-infected C6/36 cells caused intracellular 
accumulation of viral genomes and immature virus (Figure 5B, CPB1 + DENV2). However, 
overexpression of CPB1 protein in Vero cells during DENV2 infection resulted in a higher amount of 
intracellular accumulation and extracellular virus released compared to DENV2-infected cells without 
CPB1 overexpression (Figure 5C). 
It is hypothesized that, during DENV2 replication in Ae. aegypti midgut cells, CPB1 binds to the E 
proteins that are deposited on the ER intraluminal membrane or to the E proteins on immature virions. 
The interaction may reduce the encapsulation process of the newly-formed RNA into immature virus, 
resulting in DENV genomic RNA accumulation. Meanwhile, CPB1-E interaction on newly-assembled 
immature virus, including viruses that are stacked in the dilated ER cisterna, may hamper further 
processing into mature viruses in the trans-Golgi network. The accumulation of intracellular genomic 
materials or viruses causes cellular enlargement (Figure 5A, CPB1 + DENV2) and can, therefore, be 
explained by the accumulation of excessive DENV2 genomic RNA, DENV2 viral proteins and host cell 
materials [48], in addition to the cytopathic changes that occur during infection [49]. A similar effect of 
DENV genomic RNA accumulation during viral inhibition was also observed when autophagy was 
inhibited by spautin-1 (specific and potent autophagy inhibitor 1) [50]. Autophagy is required for 
optimal DENV RNA replication, and cellular lipid metabolism is necessary for energy production [51]. 
In addition, a reduction in the amount of secreted infectious virions was also observed in a study where 
the kinase inhibitor, SFV785, was used to dislocate the DENV envelope protein, thus blocking  
virus assembly [52]. 
We cannot exclude the possibility that the interaction between CPB1 and E could lead to inhibition 
of viral morphogenesis, such as viral glycoprotein processing, as described previously [53,54]. 
However, our in silico molecular modelling not only supports CPB1-E protein interaction, but also 
suggests that the residues of E protein to which CPB1 binds are Thr66, Asn67, Thr68, Lys122 and 
Val251. These residues are found in EII, and none of these residues are critical for the fusion-loop, 
hinge or E-M protein “latch” functionalities [55]. Further experimental results derived from mutational 
or isothermal titration calorimetry (ITC) analyses may support this computational finding. 
The differences in the outcomes of DENV infections between cell lines suggest that there are 
dissimilarities in viral propagation pathways between insect and mammalian host systems. Many 
studies also confirmed the differential inhibition of DENV infection in mosquito and mammalian cells 
by the dissimilarity of the DENV E protein, polysaccharide composition between virions derived from 
mosquito and mammalian cells [56,57], different antiviral susceptibility to drug inhibitors of DENV2 
entry [58] and endocytic uptake in Vero and C6/36 cells [59]. In this study, the differences in the 
outcomes could be due to several possible reasons. Firstly, CPB1 gene/protein used in the upregulation 
study is derived from mosquito. Sequence alignment conducted in our lab between the mammalian 
CPB1 (GenBank Accession Number: AAP36803.1) and mosquito CPB1 (GenBank Accession 
Number: AY590494.1) showed that the amino acid sequence homology is approximately 50%, thus 
indicating a significant differences in the protein characteristics. Therefore, the Vero cells might react 
differently to an insect CPB1 protein. Secondly, as a digestive enzyme for blood digestion after blood 
meal, CPB1 could therefore be suggested that the genes encoding the protein might be easily regulated 
in mosquitoes compared to Vero cells, where CPB1 has not been reported to be involved in any 
functional activities during DENV infection. 
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In this study, we demonstrated an anti-virus role for Ae. aegypti CPB1. Anti-viral mechanisms in 
insects have been widely studied, with reports showing delicate balances between viruses and the 
immune systems of insect vectors. These mechanisms include RNA interference (RNAi), Toll 
pathways, Janus kinase (JAK)-signal transducer and activator of transcription (STAT) (JAK-STAT) 
pathways and autophagy [60–66]. These systems control or contain viral growth, fine tune the virus 
titer and confer infectivity to the insect vector without impairing the health of the insect. Our results 
demonstrate the existence of a novel virus-control mechanism by CPB1 in the ER of Ae. aegypti 
midgut cells during DENV2 infection. 
During a blood meal from a DENV-infected human, viral infection of midgut cells occurs. It is 
hypothesized that CPB1 upregulation after a blood meal [41] functions to regulate the intracellular 
accumulation and minimal extracellular secretion of infectious DENV2. The viral infection causes 
cytopathic changes due to viral RNA and immature virus accumulation, and these cells most likely 
progress to lysis or death, followed by virus release. The released viruses are mostly immature viruses, 
CPB1-bound immature viruses and a low titer of mature infectious viruses. This may favor the health 
of the vector mosquito while keeping the virus titer at a low level to reduce infection that may cause 
devastating damage to uninfected midgut and adjacent cells. Consistent with previous studies on 
DENV and Chikungunya virus expression profiles in different mosquito organs [67–69], mosquito 
salivary glands contained a lower virus titer compared to the midgut cells. As shown in this study, 
although the small amount of virus released from the midgut cells is not likely to cause secondary 
infection in other cell types in the mosquito host, the virus titer is strategically reduced for a delicate 
balance between viruses and the immune systems of insect vectors [60–66]. Our results demonstrate 
a novel virus-control mechanism using CPB1 in the ER of Ae. aegypti midgut cells during 
DENV2 infection. 
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